TNFRSF10B and renal cell carcinoma: It has been shown that Lexa specifically binds to death receptor 5 and induces apoptosis in a number of tumor cell lines, including renal cell carcinoma (RCC) [9], human myeloma cell lines (HMCL) [10], and malignant pleural mesothelioma (MPM) [11].